These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17236554)

  • 21. Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) of Yunnan in southwestern China.
    Zhou Y; Yang Y; Yang C; Chen Y; Yang C; Du Y; Zhao G; Guo Y; Ye L; Huang Y
    Oncotarget; 2017 Feb; 8(9):15023-15033. PubMed ID: 28107191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patients.
    Wang Z; Wu YL; Zhang GC; Zhou Q; Xu CR; Guo AL
    Onkologie; 2008 Apr; 31(4):174-8. PubMed ID: 18418018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].
    Sun LN; Luan HL; Zang FL; Wang M; Dong N; Guo Y; Sun BC; Zhan ZL
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):667-70. PubMed ID: 21122380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGFR exon 20 insertion mutation in Japanese lung cancer.
    Sasaki H; Endo K; Takada M; Kawahara M; Kitahara N; Tanaka H; Okumura M; Matsumura A; Iuchi K; Kawaguchi T; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
    Lung Cancer; 2007 Dec; 58(3):324-8. PubMed ID: 17686547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions.
    Liu W; He L; Ramírez J; Krishnaswamy S; Kanteti R; Wang YC; Salgia R; Ratain MJ
    Cancer Res; 2011 Apr; 71(7):2423-7. PubMed ID: 21292812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features.
    Lai Y; Zhang Z; Li J; Sun D; Zhou Y; Jiang T; Han Y; Huang L; Zhu Y; Li X; Yan X
    Int J Mol Sci; 2013 Dec; 14(12):24549-59. PubMed ID: 24351833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].
    Dong QG; Han BH; Huang JS; Yang LM; Huang J; Zhao CY; Lu LQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):686-90. PubMed ID: 17274376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer.
    Leidner RS; Fu P; Clifford B; Hamdan A; Jin C; Eisenberg R; Boggon TJ; Skokan M; Franklin WA; Cappuzzo F; Hirsch FR; Varella-Garcia M; Halmos B
    J Clin Oncol; 2009 Nov; 27(33):5620-6. PubMed ID: 19786660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between serum CEA levels and EGFR mutations in Chinese nonsmokers with lung adenocarcinoma.
    Jin B; Dong Y; Wang HM; Huang JS; Han BH
    Acta Pharmacol Sin; 2014 Mar; 35(3):373-80. PubMed ID: 24487967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of Epidermal Growth Factor Receptor (EGFR) Gene Mutation in Formalin Fixed Paraffin Embedded Tissue by Polymerase Chain Reaction-Single Strand Conformational Polymorphism (PCR-SSCP) in Non-Small Cell Lung Cancer in the Northeastern Region of Thailand.
    Saiyaros K; Kritpetcharat P; Pairojkul C; Sithithaworn J
    Asian Pac J Cancer Prev; 2019 May; 20(5):1339-1343. PubMed ID: 31127887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.
    Tokumo M; Toyooka S; Kiura K; Shigematsu H; Tomii K; Aoe M; Ichimura K; Tsuda T; Yano M; Tsukuda K; Tabata M; Ueoka H; Tanimoto M; Date H; Gazdar AF; Shimizu N
    Clin Cancer Res; 2005 Feb; 11(3):1167-73. PubMed ID: 15709185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics].
    Tapia C; Savic S; Bihl M; Rufle A; Zlobec I; Terracciano L; Bubendorf L
    Pathologe; 2009 Sep; 30(5):384-92. PubMed ID: 19357847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancer.
    Chen HJ; Mok TS; Chen ZH; Guo AL; Zhang XC; Su J; Wu YL
    Pathol Oncol Res; 2009 Dec; 15(4):651-8. PubMed ID: 19381876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR polymorphism of the kinase domain in Japanese lung cancer.
    Sasaki H; Endo K; Takada M; Kawahara M; Tanaka H; Kitahara N; Matsumura A; Iuchi K; Kawaguchi T; Okuda K; Kawano O; Yukiue H; Yokoyama T; Yano M; Fujii Y
    J Surg Res; 2008 Aug; 148(2):260-3. PubMed ID: 18541260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
    Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
    Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer.
    Cote ML; Haddad R; Edwards DJ; Atikukke G; Gadgeel S; Soubani AO; Lonardo F; Bepler G; Schwartz AG; Ethier SP
    J Thorac Oncol; 2011 Mar; 6(3):627-30. PubMed ID: 21317742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancers by real-time polymerase chain reaction using scorpion amplification refractory mutation system].
    Zhang J; Liang ZY; Zeng X; Wu SF; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):294-9. PubMed ID: 18956645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
    Tsao AS; Tang XM; Sabloff B; Xiao L; Shigematsu H; Roth J; Spitz M; Hong WK; Gazdar A; Wistuba I
    J Thorac Oncol; 2006 Mar; 1(3):231-9. PubMed ID: 17409862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs).
    Martínez-Navarro EM; Rebollo J; González-Manzano R; Sureda M; Evgenyeva E; Valenzuela B; Fernández FJ; Forteza J; Brugarolas A
    Clin Transl Oncol; 2011 Nov; 13(11):812-8. PubMed ID: 22082647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer.
    Tu HY; Ke EE; Yang JJ; Sun YL; Yan HH; Zheng MY; Bai XY; Wang Z; Su J; Chen ZH; Zhang XC; Dong ZY; Wu SP; Jiang BY; Chen HJ; Wang BC; Xu CR; Zhou Q; Mei P; Luo DL; Zhong WZ; Yang XN; Wu YL
    Lung Cancer; 2017 Dec; 114():96-102. PubMed ID: 29173773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.